| Dr Bernard Neil Mullen Ii, MD | |
|
9040 Reid, Department Of Emergency Medicine, Madigagn Hospital, Tacoma, WA 98433 | |
| (253) 968-1250 | |
| (253) 968-2550 |
| Full Name | Dr Bernard Neil Mullen Ii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 9040 Reid, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386615276 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 24520 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bernard Neil Mullen Ii, MD 3202 N 33rd St, Tacoma, WA 98407-6004 Ph: (253) 761-0380 | Dr Bernard Neil Mullen Ii, MD 9040 Reid, Department Of Emergency Medicine, Madigagn Hospital, Tacoma, WA 98433 Ph: (253) 968-1250 |
News Archive
New research suggests that just one dose of the anesthetic ketamine appears to reduce depression in patients who show little improvement with standard medications.
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.
StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property (IP) related to the treatment of Chronic Stroke with stem cells.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and an abnormal stress test, treatment of their narrowed arteries by the common procedure of angioplasty may not provide additional benefits compared to drug therapy alone.
› Verified 8 days ago
Dr. Justin Cha-cheng Ng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-2050 | |
Robert F Wachtel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Dr. Nathan Kinneer Friedline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98433 Phone: 850-885-2273 | |
Barbara Sherry Mezger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3400 Fax: 253-596-3301 | |
Dr. Peter Stull, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 Fax: 253-968-2550 | |
Kevin E Callahan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
June A Burn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14815 Pacific Ave S, Tacoma, WA 98444 Phone: 253-697-8660 |